Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
  4. Fast Track Articles
  5. Fast Track Article
image of Beyond the Surface: Tracing the Evolution of Inflammatory Mechanism in Depression through Bibliometric Analysis
file format pdf download PDF

Abstract

Background

Depression is a common mental illness that has become a major economic burden worldwide. Recently, increasing evidence has highlighted the inflammatory mechanism of depression. In order to understand the research status of this field, this study used the bibliometric analysis method to overview the research content and progress, as well as analyze the development trend and limitations.

Methods

In this study, articles and reviews were included in the specific search strategy. The matched papers were exported from the Web of Science database. CiteSpace 6.3 R1 and Bibliometrix (R package) were utilized to generate bibliometric and knowledge maps.

Results

A total of 25,063 articles were included in this study. The number of publications in this field has gradually increased, especially in recent years. These papers come from 156 countries, led by the United States and China mainland. The leading research institution is the University of Toronto (Canada). Brain Behavior and Immunity is the journal with the most publications and the most frequently co-cited journals. Among 91,100 authors, Maes M has the most publications and co-citations. According to the keywords burst and co-cited reference analysis, the hotspots in the field in recent years include kynurenine, c-reactive protein, neuroinflammation, and gut microbiota.

Conclusion

Although abundant academic achievements have been made on the inflammatory mechanism of depression, there is still a long way to go before these research results can be applied to clinical practice. Strengthening international academic exchanges and cooperation may promote breakthroughs in this field.

© 2025 The Author(s). Published by Bentham Science Publishers
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303325541241024060229
2025-01-08
2025-05-22

  • From This Site

    /content/journals/emiddt/10.2174/0118715303325541241024060229
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. Huang Y. Li Y. Pan H. Han L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J. Glob. Health 2023 13 04160 10.7189/jogh.13.04160 38018250
    [Google Scholar]
  2. Malhi G.S. Mann J.J. Depression. Lancet 2018 392 10161 2299 2312 10.1016/S0140‑6736(18)31948‑2 30396512
    [Google Scholar]
  3. Kumar M. Njuguna S. Amin N. Kanana S. Tele A. Karanja M. Omar N. Yator O. Wambugu C. Bukusi D. Weaver M.R. Burden and risk factors of mental and substance use disorders among adolescents and young adults in Kenya: Results from the global burden of disease study 2019. EClinicalMedicine 2024 67 102328 10.1016/j.eclinm.2023.102328 38204491
    [Google Scholar]
  4. Factsheets: Depression 2021 Available from: www.who.int/news- room/fact-sheets/detail/depression
  5. Santomauro D.F. Mantilla Herrera A.M. Shadid J. Zheng P. Ashbaugh C. Pigott D.M. Abbafati C. Adolph C. Amlag J.O. Aravkin A.Y. Bang-Jensen B.L. Bertolacci G.J. Bloom S.S. Castellano R. Castro E. Chakrabarti S. Chattopadhyay J. Cogen R.M. Collins J.K. Dai X. Dangel W.J. Dapper C. Deen A. Erickson M. Ewald S.B. Flaxman A.D. Frostad J.J. Fullman N. Giles J.R. Giref A.Z. Guo G. He J. Helak M. Hulland E.N. Idrisov B. Lindstrom A. Linebarger E. Lotufo P.A. Lozano R. Magistro B. Malta D.C. Månsson J.C. Marinho F. Mokdad A.H. Monasta L. Naik P. Nomura S. O’Halloran J.K. Ostroff S.M. Pasovic M. Penberthy L. Reiner R.C. Jr Reinke G. Ribeiro A.L.P. Sholokhov A. Sorensen R.J.D. Varavikova E. Vo A.T. Walcott R. Watson S. Wiysonge C.S. Zigler B. Hay S.I. Vos T. Murray C.J.L. Whiteford H.A. Ferrari A.J. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021 398 10312 1700 1712 10.1016/S0140‑6736(21)02143‑7 34634250
    [Google Scholar]
  6. Pirkis J. John A. Shin S. DelPozo-Banos M. Arya V. Analuisa-Aguilar P. Appleby L. Arensman E. Bantjes J. Baran A. Bertolote J.M. Borges G. Brečić P. Caine E. Castelpietra G. Chang S.S. Colchester D. Crompton D. Curkovic M. Deisenhammer E.A. Du C. Dwyer J. Erlangsen A. Faust J.S. Fortune S. Garrett A. George D. Gerstner R. Gilissen R. Gould M. Hawton K. Kanter J. Kapur N. Khan M. Kirtley O.J. Knipe D. Kolves K. Leske S. Marahatta K. Mittendorfer-Rutz E. Neznanov N. Niederkrotenthaler T. Nielsen E. Nordentoft M. Oberlerchner H. O’Connor R.C. Pearson M. Phillips M.R. Platt S. Plener P.L. Psota G. Qin P. Radeloff D. Rados C. Reif A. Reif-Leonhard C. Rozanov V. Schlang C. Schneider B. Semenova N. Sinyor M. Townsend E. Ueda M. Vijayakumar L. Webb R.T. Weerasinghe M. Zalsman G. Gunnell D. Spittal M.J. Suicide trends in the early months of the COVID-19 pandemic: An interrupted time-series analysis of preliminary data from 21 countries. Lancet Psychiatry 2021 8 7 579 588 10.1016/S2215‑0366(21)00091‑2 33862016
    [Google Scholar]
  7. Miguel T.L. Berti R. Blazhenets G. Domogalla L.C. Steinacker N. Omrane M.A. Meyer P.T. Coenen V.A. Eder A.C. Döbrössy M.D. Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation. Prog. Neuropsychopharmacol. Biol. Psychiatry 2024 133 111013 10.1016/j.pnpbp.2024.111013 38636702
    [Google Scholar]
  8. Xu Y. Li R. Hu C. He Y. Zhang X. Jin L. Global, regional, and national incidence trends of depressive disorder, 1990–2019: An age-period-cohort analysis based on the global burden of disease 2019 study. Gen. Hosp. Psychiatry 2024 88 51 60 10.1016/j.genhosppsych.2024.03.003 38508076
    [Google Scholar]
  9. Murray C.J.L. Aravkin A.Y. Zheng P. Abbafati C. Abbas K.M. Abbasi-Kangevari M. Abd-Allah F. Abdelalim A. Abdollahi M. Abdollahpour I. Abegaz K.H. Abolhassani H. Aboyans V. Abreu L.G. Abrigo M.R.M. Abualhasan A. Abu-Raddad L.J. Abushouk A.I. Adabi M. Adekanmbi V. Adeoye A.M. Adetokunboh O.O. Adham D. Advani S.M. Agarwal G. Aghamir S.M.K. Agrawal A. Ahmad T. Ahmadi K. Ahmadi M. Ahmadieh H. Ahmed M.B. Akalu T.Y. Akinyemi R.O. Akinyemiju T. Akombi B. Akunna C.J. Alahdab F. Al-Aly Z. Alam K. Alam S. Alam T. Alanezi F.M. Alanzi T.M. Alemu B. Alhabib K.F. Ali M. Ali S. Alicandro G. Alinia C. Alipour V. Alizade H. Aljunid S.M. Alla F. Allebeck P. Almasi-Hashiani A. Al-Mekhlafi H.M. Alonso J. Altirkawi K.A. Amini-Rarani M. Amiri F. Amugsi D.A. Ancuceanu R. Anderlini D. Anderson J.A. Andrei C.L. Andrei T. Angus C. Anjomshoa M. Ansari F. Ansari-Moghaddam A. Antonazzo I.C. Antonio C.A.T. Antony C.M. Antriyandarti E. Anvari D. Anwer R. Appiah S.C.Y. Arabloo J. Arab-Zozani M. Ariani F. Armoon B. Ärnlöv J. Arzani A. Asadi-Aliabadi M. Asadi-Pooya A.A. Ashbaugh C. Assmus M. Atafar Z. Atnafu D.D. Atout M.M.W. Ausloos F. Ausloos M. Ayala Q.B.P. Ayano G. Ayanore M.A. Azari S. Azarian G. Azene Z.N. Badawi A. Badiye A.D. Bahrami M.A. Bakhshaei M.H. Bakhtiari A. Bakkannavar S.M. Baldasseroni A. Ball K. Ballew S.H. Balzi D. Banach M. Banerjee S.K. Bante A.B. Baraki A.G. Barker-Collo S.L. Bärnighausen T.W. Barrero L.H. Barthelemy C.M. Barua L. Basu S. Baune B.T. Bayati M. Becker J.S. Bedi N. Beghi E. Béjot Y. Bell M.L. Bennitt F.B. Bensenor I.M. Berhe K. Berman A.E. Bhagavathula A.S. Bhageerathy R. Bhala N. Bhandari D. Bhattacharyya K. Bhutta Z.A. Bijani A. Bikbov B. Bin Sayeed M.S. Biondi A. Birihane B.M. Bisignano C. Biswas R.K. Bitew H. Bohlouli S. Bohluli M. Boon-Dooley A.S. Borges G. Borzì A.M. Borzouei S. Bosetti C. Boufous S. Braithwaite D. Breitborde N.J.K. Breitner S. Brenner H. Briant P.S. Briko A.N. Briko N.I. Britton G.B. Bryazka D. Bumgarner B.R. Burkart K. Burnett R.T. Burugina N.S. Butt Z.A. Caetano dos Santos F.L. Cahill L.E. Cámera L.L.A.A. Campos-Nonato I.R. Cárdenas R. Carreras G. Carrero J.J. Carvalho F. Castaldelli-Maia J.M. Castañeda-Orjuela C.A. Castelpietra G. Castro F. Causey K. Cederroth C.R. Cercy K.M. Cerin E. Chandan J.S. Chang K-L. Charlson F.J. Chattu V.K. Chaturvedi S. Cherbuin N. Chimed-Ochir O. Cho D.Y. Choi J-Y.J. Christensen H. Chu D-T. Chung M.T. Chung S-C. Cicuttini F.M. Ciobanu L.G. Cirillo M. Classen T.K.D. Cohen A.J. Compton K. Cooper O.R. Costa V.M. Cousin E. Cowden R.G. Cross D.H. Cruz J.A. Dahlawi S.M.A. Damasceno A.A.M. Damiani G. Dandona L. Dandona R. Dangel W.J. Danielsson A-K. Dargan P.I. Darwesh A.M. Daryani A. Das J.K. Das Gupta R. das Neves J. Dávila-Cervantes C.A. Davitoiu D.V. De Leo D. Degenhardt L. DeLang M. Dellavalle R.P. Demeke F.M. Demoz G.T. Demsie D.G. Denova-Gutiérrez E. Dervenis N. Dhungana G.P. Dianatinasab M. Dias da Silva D. Diaz D. Dibaji F.Z.S. Djalalinia S. Do H.T. Dokova K. Dorostkar F. Doshmangir L. Driscoll T.R. Duncan B.B. Duraes A.R. Eagan A.W. Edvardsson D. El Nahas N. El Sayed I. El Tantawi M. Elbarazi I. Elgendy I.Y. El-Jaafary S.I. Elyazar I.R.F. Emmons-Bell S. Erskine H.E. Eskandarieh S. Esmaeilnejad S. Esteghamati A. Estep K. Etemadi A. Etisso A.E. Fanzo J. Farahmand M. Fareed M. Faridnia R. Farioli A. Faro A. Faruque M. Farzadfar F. Fattahi N. Fazlzadeh M. Feigin V.L. Feldman R. Fereshtehnejad S-M. Fernandes E. Ferrara G. Ferrari A.J. Ferreira M.L. Filip I. Fischer F. Fisher J.L. Flor L.S. Foigt N.A. Folayan M.O. Fomenkov A.A. Force L.M. Foroutan M. Franklin R.C. Freitas M. Fu W. Fukumoto T. Furtado J.M. Gad M.M. Gakidou E. Gallus S. Garcia-Basteiro A.L. Gardner W.M. Geberemariyam B.S. Gebreslassie A.A.A.A. Geremew A. Gershberg H.A. Gething P.W. Ghadimi M. Ghadiri K. Ghaffarifar F. Ghafourifard M. Ghamari F. Ghashghaee A. Ghiasvand H. Ghith N. Gholamian A. Ghosh R. Gill P.S. Ginindza T.G.G. Giussani G. Gnedovskaya E.V. Goharinezhad S. Gopalani S.V. Gorini G. Goudarzi H. Goulart A.C. Greaves F. Grivna M. Grosso G. Gubari M.I.M. Gugnani H.C. Guimarães R.A. Guled R.A. Guo G. Guo Y. Gupta R. Gupta T. Haddock B. Hafezi-Nejad N. Hafiz A. Haj-Mirzaian A. Haj-Mirzaian A. Hall B.J. Halvaei I. Hamadeh R.R. Hamidi S. Hammer M.S. Hankey G.J. Haririan H. Haro J.M. Hasaballah A.I. Hasan M.M. Hasanpoor E. Hashi A. Hassanipour S. Hassankhani H. Havmoeller R.J. Hay S.I. Hayat K. Heidari G. Heidari-Soureshjani R. Henrikson H.J. Herbert M.E. Herteliu C. Heydarpour F. Hird T.R. Hoek H.W. Holla R. Hoogar P. Hosgood H.D. Hossain N. Hosseini M. Hosseinzadeh M. Hostiuc M. Hostiuc S. Househ M. Hsairi M. Hsieh V.C. Hu G. Hu K. Huda T.M. Humayun A. Huynh C.K. Hwang B-F. Iannucci V.C. Ibitoye S.E. Ikeda N. Ikuta K.S. Ilesanmi O.S. Ilic I.M. Ilic M.D. Inbaraj L.R. Ippolito H. Iqbal U. Irvani S.S.N. Irvine C.M.S. Islam M.M. Islam S.M.S. Iso H. Ivers R.Q. Iwu C.C.D. Iwu C.J. Iyamu I.O. Jaafari J. Jacobsen K.H. Jafari H. Jafarinia M. Jahani M.A. Jakovljevic M. Jalilian F. James S.L. Janjani H. Javaheri T. Javidnia J. Jeemon P. Jenabi E. Jha R.P. Jha V. Ji J.S. Johansson L. John O. John-Akinola Y.O. Johnson C.O. Jonas J.B. Joukar F. Jozwiak J.J. Jürisson M. Kabir A. Kabir Z. Kalani H. Kalani R. Kalankesh L.R. Kalhor R. Kanchan T. Kapoor N. Karami Matin B. Karch A. Karim M.A. Kassa G.M. Katikireddi S.V. Kayode G.A. Kazemi K.A. Keiyoro P.N. Keller C. Kemmer L. Kendrick P.J. Khalid N. Khammarnia M. Khan E.A. Khan M. Khatab K. Khater M.M. Khatib M.N. Khayamzadeh M. Khazaei S. Kieling C. Kim Y.J. Kimokoti R.W. Kisa A. Kisa S. Kivimäki M. Knibbs L.D. Knudsen A.K.S. Kocarnik J.M. Kochhar S. Kopec J.A. Korshunov V.A. Koul P.A. Koyanagi A. Kraemer M.U.G. Krishan K. Krohn K.J. Kromhout H. Kuate D.B. Kumar G.A. Kumar V. Kurmi O.P. Kusuma D. La Vecchia C. Lacey B. Lal D.K. Lalloo R. Lallukka T. Lami F.H. Landires I. Lang J.J. Langan S.M. Larsson A.O. Lasrado S. Lauriola P. Lazarus J.V. Lee P.H. Lee S.W.H. LeGrand K.E. Leigh J. Leonardi M. Lescinsky H. Leung J. Levi M. Li S. Lim L-L. Linn S. Liu S. Liu S. Liu Y. Lo J. Lopez A.D. Lopez J.C.F. Lopukhov P.D. Lorkowski S. Lotufo P.A. Lu A. Lugo A. Maddison E.R. Mahasha P.W. Mahdavi M.M. Mahmoudi M. Majeed A. Maleki A. Maleki S. Malekzadeh R. Malta D.C. Mamun A.A. Manda A.L. Manguerra H. Mansour-Ghanaei F. Mansouri B. Mansournia M.A. Mantilla H.A.M. Maravilla J.C. Marks A. Martin R.V. Martini S. Martins-Melo F.R. Masaka A. Masoumi S.Z. Mathur M.R. Matsushita K. Maulik P.K. McAlinden C. McGrath J.J. McKee M. Mehndiratta M.M. Mehri F. Mehta K.M. Memish Z.A. Mendoza W. Menezes R.G. Mengesha E.W. Mereke A. Mereta S.T. Meretoja A. Meretoja T.J. Mestrovic T. Miazgowski B. Miazgowski T. Michalek I.M. Miller T.R. Mills E.J. Mini G.K. Miri M. Mirica A. Mirrakhimov E.M. Mirzaei H. Mirzaei M. Mirzaei R. Mirzaei-Alavijeh M. Misganaw A.T. Mithra P. Moazen B. Mohammad D.K. Mohammad Y. Mohammad G.M.N. Mohammadian-Hafshejani A. Mohammadifard N. Mohammadpourhodki R. Mohammed A.S. Mohammed H. Mohammed J.A. Mohammed S. Mokdad A.H. Molokhia M. Monasta L. Mooney M.D. Moradi G. Moradi M. Moradi-Lakeh M. Moradzadeh R. Moraga P. Morawska L. Morgado-da-Costa J. Morrison S.D. Mosapour A. Mosser J.F. Mouodi S. Mousavi S.M. Mousavi K.A. Mueller U.O. Mukhopadhyay S. Mullany E.C. Musa K.I. Muthupandian S. Nabhan A.F. Naderi M. Nagarajan A.J. Nagel G. Naghavi M. Naghshtabrizi B. Naimzada M.D. Najafi F. Nangia V. Nansseu J.R. Naserbakht M. Nayak V.C. Negoi I. Ngunjiri J.W. Nguyen C.T. Nguyen H.L.T. Nguyen M. Nigatu Y.T. Nikbakhsh R. Nixon M.R. Nnaji C.A. Nomura S. Norrving B. Noubiap J.J. Nowak C. Nunez-Samudio V. Oţoiu A. Oancea B. Odell C.M. Ogbo F.A. Oh I-H. Okunga E.W. Oladnabi M. Olagunju A.T. Olusanya B.O. Olusanya J.O. Omer M.O. Ong K.L. Onwujekwe O.E. Orpana H.M. Ortiz A. Osarenotor O. Osei F.B. Ostroff S.M. Otstavnov N. Otstavnov S.S. Øverland S. Owolabi M.O. P A M. Padubidri J.R. Palladino R. Panda-Jonas S. Pandey A. Parry C.D.H. Pasovic M. Pasupula D.K. Patel S.K. Pathak M. Patten S.B. Patton G.C. Pazoki T.H. Peden A.E. Pennini A. Pepito V.C.F. Peprah E.K. Pereira D.M. Pesudovs K. Pham H.Q. Phillips M.R. Piccinelli C. Pilz T.M. Piradov M.A. Pirsaheb M. Plass D. Polinder S. Polkinghorne K.R. Pond C.D. Postma M.J. Pourjafar H. Pourmalek F. Poznańska A. Prada S.I. Prakash V. Pribadi D.R.A. Pupillo E. Quazi Syed Z. Rabiee M. Rabiee N. Radfar A. Rafiee A. Raggi A. Rahman M.A. Rajabpour-Sanati A. Rajati F. Rakovac I. Ram P. Ramezanzadeh K. Ranabhat C.L. Rao P.C. Rao S.J. Rashedi V. Rathi P. Rawaf D.L. Rawaf S. Rawal L. Rawassizadeh R. Rawat R. Razo C. Redford S.B. Reiner R.C. Jr Reitsma M.B. Remuzzi G. Renjith V. Renzaho A.M.N. Resnikoff S. Rezaei N. Rezaei N. Rezapour A. Rhinehart P-A. Riahi S.M. Ribeiro D.C. Ribeiro D. Rickard J. Rivera J.A. Roberts N.L.S. Rodríguez-Ramírez S. Roever L. Ronfani L. Room R. Roshandel G. Roth G.A. Rothenbacher D. Rubagotti E. Rwegerera G.M. Sabour S. Sachdev P.S. Saddik B. Sadeghi E. Sadeghi M. Saeedi R. Saeedi M.S. Safari Y. Safi S. Safiri S. Sagar R. Sahebkar A. Sajadi S.M. Salam N. Salamati P. Salem H. Salem M.R.R. Salimzadeh H. Salman O.M. Salomon J.A. Samad Z. Samadi Kafil H. Sambala E.Z. Samy A.M. Sanabria J. Sánchez-Pimienta T.G. Santomauro D.F. Santos I.S. Santos J.V. Santric-Milicevic M.M. Saraswathy S.Y.I. Sarmiento-Suárez R. Sarrafzadegan N. Sartorius B. Sarveazad A. Sathian B. Sathish T. Sattin D. Saxena S. Schaeffer L.E. Schiavolin S. Schlaich M.P. Schmidt M.I. Schutte A.E. Schwebel D.C. Schwendicke F. Senbeta A.M. Senthilkumaran S. Sepanlou S.G. Serdar B. Serre M.L. Shadid J. Shafaat O. Shahabi S. Shaheen A.A. Shaikh M.A. Shalash A.S. Shams-Beyranvand M. Shamsizadeh M. Sharafi K. Sheikh A. Sheikhtaheri A. Shibuya K. Shield K.D. Shigematsu M. Shin J.I. Shin M-J. Shiri R. Shirkoohi R. Shuval K. Siabani S. Sierpinski R. Sigfusdottir I.D. Sigurvinsdottir R. Silva J.P. Simpson K.E. Singh J.A. Singh P. Skiadaresi E. Skou S.T. Skryabin V.Y. Smith E.U.R. Soheili A. Soltani S. Soofi M. Sorensen R.J.D. Soriano J.B. Sorrie M.B. Soshnikov S. Soyiri I.N. Spencer C.N. Spotin A. Sreeramareddy C.T. Srinivasan V. Stanaway J.D. Stein C. Stein D.J. Steiner C. Stockfelt L. Stokes M.A. Straif K. Stubbs J.L. Sufiyan M.B. Suleria H.A.R. Suliankatchi A.R. Sulo G. Sultan I. Szumowski Ł. Tabarés-Seisdedos R. Tabb K.M. Tabuchi T. Taherkhani A. Tajdini M. Takahashi K. Takala J.S. Tamiru A.T. Taveira N. Tehrani-Banihashemi A. Temsah M-H. Tesema G.A. Tessema Z.T. Thurston G.D. Titova M.V. Tohidinik H.R. Tonelli M. Topor-Madry R. Topouzis F. Torre A.E. Touvier M. Tovani-Palone M.R.R. Tran B.X. Travillian R. Tsatsakis A. Tudor Car L. Tyrovolas S. Uddin R. Umeokonkwo C.D. Unnikrishnan B. Upadhyay E. Vacante M. Valdez P.R. van Donkelaar A. Vasankari T.J. Vasseghian Y. Veisani Y. Venketasubramanian N. Violante F.S. Vlassov V. Vollset S.E. Vos T. Vukovic R. Waheed Y. Wallin M.T. Wang Y. Wang Y-P. Watson A. Wei J. Wei M.Y.W. Weintraub R.G. Weiss J. Werdecker A. West J.J. Westerman R. Whisnant J.L. Whiteford H.A. Wiens K.E. Wolfe C.D.A. Wozniak S.S. Wu A-M. Wu J. Wulf H.S. Xu G. Xu R. Yadgir S. Yahyazadeh J.S.H. Yamagishi K. Yaminfirooz M. Yano Y. Yaya S. Yazdi-Feyzabadi V. Yeheyis T.Y. Yilgwan C.S. Yilma M.T. Yip P. Yonemoto N. Younis M.Z. Younker T.P. Yousefi B. Yousefi Z. Yousefinezhadi T. Yousuf A.Y. Yu C. Yusefzadeh H. Zahirian M.T. Zamani M. Zamanian M. Zandian H. Zastrozhin M.S. Zhang Y. Zhang Z-J. Zhao J.T. Zhao X-J.G. Zhao Y. Zhou M. Ziapour A. Zimsen S.R.M. Brauer M. Afshin A. Lim S.S. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. Lancet 2020 396 10258 1223 1249 10.1016/S0140‑6736(20)30752‑2 33069327
    [Google Scholar]
  10. Yang F. Lodder P. Huang N. Liu X. Fu M. Guo J. Thirty-year trends of depressive disorders in 204 countries and territories from 1990 to 2019: An age-period-cohort analysis. Psychiatry Res. 2023 328 115433 10.1016/j.psychres.2023.115433 37651839
    [Google Scholar]
  11. Maes M. Mihaylova I. Kubera M. Ringel K. Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012 36 1 169 175 10.1016/j.pnpbp.2011.09.006 21945535
    [Google Scholar]
  12. Miller A.H. Maletic V. Raison C.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009 65 9 732 741 10.1016/j.biopsych.2008.11.029 19150053
    [Google Scholar]
  13. Kokras N. Hodes G.E. Bangasser D.A. Dalla C. Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development? Br. J. Pharmacol. 2019 176 21 4090 4106 10.1111/bph.14710 31093959
    [Google Scholar]
  14. Lynall M.E. McIntosh A.M. The heterogeneity of depression. Am. J. Psychiatry 2023 180 10 703 704 10.1176/appi.ajp.20230574 37777851
    [Google Scholar]
  15. Liu L. Wang H. Chen X. Zhang Y. Zhang H. Xie P. Gut microbiota and its metabolites in depression: From pathogenesis to treatment. EBioMedicine 2023 90 104527 10.1016/j.ebiom.2023.104527 36963238
    [Google Scholar]
  16. Goldsmith D.R. Bekhbat M. Mehta N.D. Felger J.C. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. Biol. Psychiatry 2023 93 5 405 418 10.1016/j.biopsych.2022.11.003 36725140
    [Google Scholar]
  17. Johnston J.N. Greenwald M.S. Henter I.D. Kraus C. Mkrtchian A. Clark N.G. Park L.T. Gold P. Zarate C.A. Jr Kadriu B. Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile. Drug Discov. Today 2023 28 4 103518 10.1016/j.drudis.2023.103518 36758932
    [Google Scholar]
  18. Kunugi H. Depression and lifestyle: Focusing on nutrition, exercise, and their possible relevance to molecular mechanisms. Psychiatry Clin. Neurosci. 2023 77 8 420 433 10.1111/pcn.13551 36992617
    [Google Scholar]
  19. Smith R.S. The macrophage theory of depression. Med. Hypotheses 1991 35 4 298 306 10.1016/0306‑9877(91)90272‑Z 1943879
    [Google Scholar]
  20. Maes M. Smith R. Simon S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995 20 2 111 116 10.1016/0306‑4530(94)00066‑J 7899532
    [Google Scholar]
  21. Woelfer M. Kasties V. Kahlfuss S. Walter M. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience 2019 403 93 110 10.1016/j.neuroscience.2018.03.034 29604382
    [Google Scholar]
  22. Hotamisligil G.S. Inflammation, metaflammation and immunometabolic disorders. Nature 2017 542 7640 177 185 10.1038/nature21363 28179656
    [Google Scholar]
  23. Karanikas E. Vlasidou D.I. Psychologically traumatic stress inducing redox – inflammation interplay; which comes first? Pharmacol. Biochem. Behav. 2021 209 173254 10.1016/j.pbb.2021.173254 34400213
    [Google Scholar]
  24. Bauer M.E. Teixeira A.L. Inflammation in psychiatric disorders: What comes first? Ann. N. Y. Acad. Sci. 2019 1437 1 57 67 10.1111/nyas.13712 29752710
    [Google Scholar]
  25. Braillon A. Fried E.I. Cristea I.A. Cosgrove L. Naudet F. Treatments for major depression. Lancet 2023 401 10394 2110 10.1016/S0140‑6736(23)00953‑4 37355287
    [Google Scholar]
  26. Telis N. Lehmann B.V. Feldman M.W. Pritchard J.K. A bibliometric history of the journal GENETICS. Genetics 2016 204 4 1337 1342 10.1534/genetics.116.196964 27927899
    [Google Scholar]
  27. Jiang S. Liu Y. Zheng H. Zhang L. Zhao H. Sang X. Xu Y. Lu X. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: A bibliometric analysis. Int. J. Surg. 2023 109 9 2774 2783 10.1097/JS9.0000000000000492 37216225
    [Google Scholar]
  28. Ye L. Liang R. Liu X. Li J. Yue J. Zhang X. Frailty and sarcopenia: A bibliometric analysis of their association and potential targets for intervention. Ageing Res. Rev. 2023 92 102111 10.1016/j.arr.2023.102111 38031836
    [Google Scholar]
  29. Chen C. Searching for intellectual turning points: Progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004 101 Suppl 1 Suppl 1 5303 5310 10.1073/pnas.0307513100
    [Google Scholar]
  30. Zou X. Sun Y. Bibliometrics analysis of the research status and trends of the association between depression and insulin from 2010 to 2020. Front. Psychiatry 2021 12 683474 10.3389/fpsyt.2021.683474 34366917
    [Google Scholar]
  31. Maes M. Ombelet W. Verkerk R. Bosmans E. Scharpé S. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: Relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol. Med. 2001 31 5 847 858 10.1017/S0033291701004007 11459382
    [Google Scholar]
  32. Maes M. The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 2001 16 1 95 103 10.1002/hup.191 12404604
    [Google Scholar]
  33. Musselman D.L. Lawson D.H. Gumnick J.F. Manatunga A.K. Penna S. Goodkin R.S. Greiner K. Nemeroff C.B. Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 2001 344 13 961 966 10.1056/NEJM200103293441303 11274622
    [Google Scholar]
  34. Kudoh A. Katagai H. Takazawa T. Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients. Cytokine 2001 13 2 104 108 10.1006/cyto.2000.0802 11145850
    [Google Scholar]
  35. Godbout JP Moreau M Lestage J Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. europsychopharmacology. 2008 33 10 2341 2351 10.1038/sj.npp.1301649
    [Google Scholar]
  36. McNally L. Bhagwagar Z. Hannestad J. Inflammation, glutamate, and glia in depression: A literature review. CNS Spectr. 2008 13 6 501 510 10.1017/S1092852900016734 18567974
    [Google Scholar]
  37. Depression and Other Common Mental Disorders: Global Health Estimates World Health Organization Geneva 2017
    [Google Scholar]
  38. Kiraz S. Demir E. Global scientific outputs of schizophrenia publications from 1975 to 2020: A bibliometric analysis. Psychiatr. Q. 2021 92 4 1725 1744 10.1007/s11126‑021‑09937‑4 34341886
    [Google Scholar]
  39. Chen P. Bai W. Li X.H. Feng Y. Cheung T. Su Z. Balbuena L. Xiang Y.T. Research on major depression in China: A perspective from bibliometric analysis. J. Affect. Disord. 2022 315 174 181 10.1016/j.jad.2022.07.046 35907481
    [Google Scholar]
  40. Mcdonald E.M. Mann A.H. Thomas H.C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 1987 330 8569 1175 1178 10.1016/S0140‑6736(87)91319‑5 2890808
    [Google Scholar]
  41. Beurel E. Toups M. Nemeroff C.B. The bidirectional relationship of depression and inflammation: Double trouble. Neuron 2020 107 2 234 256 10.1016/j.neuron.2020.06.002 32553197
    [Google Scholar]
  42. Zhang Y. Liu L. Peng Y.L. Liu Y.Z. Wu T.Y. Shen X.L. Zhou J.R. Sun D.Y. Huang A.J. Wang X. Wang Y.X. Jiang C.L. Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci. Ther. 2014 20 2 119 124 10.1111/cns.12170 24279434
    [Google Scholar]
  43. Dantzer R. O’Connor J.C. Freund G.G. Johnson R.W. Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008 9 1 46 56 10.1038/nrn2297 18073775
    [Google Scholar]
  44. Raison C.L. Rutherford R.E. Woolwine B.J. Shuo C. Schettler P. Drake D.F. Haroon E. Miller A.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 2013 70 1 31 41 10.1001/2013.jamapsychiatry.4 22945416
    [Google Scholar]
  45. Jones B.D.M. Mahmood U. Hodsoll J. Chaudhry I.B. Khoso A.B. Husain M.O. Ortiz A. Husain N. Mulsant B.H. Young A.H. Husain M.I. Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country. CNS Spectr. 2023 28 6 710 718 10.1017/S1092852923002316 37160707
    [Google Scholar]
  46. Young J.J. Bruno D. Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J. Affect. Disord. 2014 169 15 20 10.1016/j.jad.2014.07.032 25128861
    [Google Scholar]
  47. Howren M.B. Lamkin D.M. Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom. Med. 2009 71 2 171 186 10.1097/PSY.0b013e3181907c1b 19188531
    [Google Scholar]
  48. Barberio B. Zamani M. Black C.J. Savarino E.V. Ford A.C. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2021 6 5 359 370 10.1016/S2468‑1253(21)00014‑5 33721557
    [Google Scholar]
  49. Moustafa A.T. Moazzami M. Engel L. Bangert E. Hassanein M. Marzouk S. Kravtsenyuk M. Fung W. Eder L. Su J. Wither J.E. Touma Z. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin. Arthritis Rheum. 2020 50 1 84 94 10.1016/j.semarthrit.2019.06.017 31303437
    [Google Scholar]
  50. Chan V.K.Y. Luo H. Chan S.S.M. Lau C.S. Yeung W.W.Y. Peng K. Tong X. Lam M.P.S. Wong I.C.K. Li X. Treatment-resistant depression and risk of autoimmune diseases: evidence from a population-based cohort and nested case-control study. Transl. Psychiatry 2023 13 1 76 10.1038/s41398‑023‑02383‑9 36864045
    [Google Scholar]
  51. Shimo Y. Cathomas F. Lin H. Chan K.L. Parise L.F. Li L. Ferrer-Pérez C. Muhareb S. Costi S. Murrough J.W. Russo S.J. Social stress induces autoimmune responses against the brain. Proc. Natl. Acad. Sci. USA 2023 120 49 e2305778120 10.1073/pnas.2305778120 38011565
    [Google Scholar]
  52. Fotopoulos A. Petrikis P. Sioka C. Depression and coronary artery disease. Psychiatr. Danub. 2021 33 1 73 33857047
    [Google Scholar]
  53. McFarland D.C. Doherty M. Atkinson T.M. O’Hanlon R. Breitbart W. Nelson C.J. Miller A.H. Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis. Cancer 2022 128 13 2504 2519 10.1002/cncr.34193 35417925
    [Google Scholar]
  54. Gold S.M. Köhler-Forsberg O. Moss-Morris R. Mehnert A. Miranda J.J. Bullinger M. Steptoe A. Whooley M.A. Otte C. Comorbid depression in medical diseases. Nat. Rev. Dis. Primers 2020 6 1 69 10.1038/s41572‑020‑0200‑2 32820163
    [Google Scholar]
  55. Milo F. Imondi C. D’Amore C. Angelino G. Knafelz D. Bracci F. Dall’Oglio L. De Angelis P. Tabarini P. Short-term psychodynamic psychotherapy in addition to standard medical therapy increases clinical remission in adolescents and young adults with inflammatory bowel disease: A randomised controlled trial. J. Crohn’s Colitis 2024 18 2 256 263 10.1093/ecco‑jcc/jjad145 37621051
    [Google Scholar]
  56. Akechi T. Yamaguchi T. Uchida M. Imai F. Momino K. Katsuki F. Sakurai N. Miyaji T. Mashiko T. Horikoshi M. Furukawa T.A. Yoshimura A. Ohno S. Uehiro N. Higaki K. Hasegawa Y. Akahane K. Uchitomi Y. Iwata H. Smartphone psychotherapy reduces fear of cancer recurrence among breast cancer survivors: A fully decentralized randomized controlled clinical trial (J-SUPPORT 1703 Study). J. Clin. Oncol. 2023 41 5 1069 1078 10.1200/JCO.22.00699 36322882
    [Google Scholar]
  57. Koizumi T. Sugishita Y. Suzuki-Takahashi Y. Nara K. Miyagawa T. Nakajima M. Sugimoto K. Futamura M. Furui T. Takai Y. Matsumoto H. Yamauchi H. Ohno S. Kataoka A. Kawai K. Fukuma E. Nogi H. Tsugawa K. Suzuki N. Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial. Cancer 2023 129 16 2568 2580 10.1002/cncr.34796 37082910
    [Google Scholar]
  58. Benson S. Engler H. Wegner A. Rebernik L. Spreitzer I. Schedlowski M. Elsenbruch S. What makes you feel sick after inflammation? predictors of acute and persisting physical sickness symptoms induced by experimental endotoxemia. Clin. Pharmacol. Ther. 2017 102 1 141 151 10.1002/cpt.618 28074475
    [Google Scholar]
  59. Balter L.J.T. Li X. Schwieler L. Erhardt S. Axelsson J. Olsson M.J. Lasselin J. Lekander M. Lipopolysaccharide-induced changes in the kynurenine pathway and symptoms of sickness behavior in humans. Psychoneuroendocrinology 2023 153 106110 10.1016/j.psyneuen.2023.106110 37075653
    [Google Scholar]
  60. Schaefer M. Engelbrechta M.A. Gut O. Fiebich B.L. Bauer J. Schmidt F. Grunze H. Lieb K. Interferon alpha (IFNα) and psychiatric syndromes. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002 26 4 731 746 10.1016/S0278‑5846(01)00324‑4 12188106
    [Google Scholar]
  61. Xie X. Wu X. Zhao D. Liu Y. Du Q. Li Y. Xu Y. Li Y. Qiu Y. Yang Y. Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway. Pharmacol. Res. 2023 187 106577 10.1016/j.phrs.2022.106577 36435270
    [Google Scholar]
  62. Kappelmann N. Lewis G. Dantzer R. Jones P.B. Khandaker G.M. Antidepressant activity of anti-cytokine treatment: A systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol. Psychiatry 2018 23 2 335 343 10.1038/mp.2016.167 27752078
    [Google Scholar]
  63. Min X. Wang G. Cui Y. Meng P. Hu X. Liu S. Wang Y. Association between inflammatory cytokines and symptoms of major depressive disorder in adults. Front. Immunol. 2023 14 1110775 10.3389/fimmu.2023.1110775 36860860
    [Google Scholar]
  64. Yang Y. Gu K. Meng C. Li J. Lu Q. Zhou X. Yan D. Li D. Pei C. Lu Y. Ran S. Li J. Relationship between sleep and serum inflammatory factors in patients with major depressive disorder. Psychiatry Res. 2023 329 115528 10.1016/j.psychres.2023.115528 37837811
    [Google Scholar]
  65. Poletti S. Zanardi R. Mandelli A. Aggio V. Finardi A. Lorenzi C. Borsellino G. Carminati M. Manfredi E. Tomasi E. Spadini S. Colombo C. Drexhage H.A. Furlan R. Benedetti F. Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers. Brain Behav. Immun. 2024 118 52 68 10.1016/j.bbi.2024.02.019 38367846
    [Google Scholar]
  66. Esalatmanesh S. Kashani L. Khooshideh M. Moghaddam H.S. Ansari S. Akhondzadeh S. Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: A randomized, double-blind, placebo-controlled trial. Arch. Gynecol. Obstet. 2023 309 4 1429 1439 10.1007/s00404‑023‑07042‑4 37097311
    [Google Scholar]
  67. Merza M.T.A. Salman D.M. Jaafar H.M. Pentoxifylline as a novel add-on therapy for major depressive disorder in adult patients: A randomized, double-blind, placebo-controlled trial. Pharmacopsychiatry 2024 57 4 205 214 10.1055/a‑2291‑7204 38710206
    [Google Scholar]
  68. Borbély É. Simon M. Fuchs E. Wiborg O. Czéh B. Helyes Z. Novel drug developmental strategies for treatment‐resistant depression. Br. J. Pharmacol. 2022 179 6 1146 1186 10.1111/bph.15753 34822719
    [Google Scholar]
  69. Chen Y. Zhang Y. Wang J. Li S. Wang Y. Zhang Z. Zhang J. Xin C. Wang Y. Rong P. Anti-neuroinflammation effects of transcutaneous auricular vagus nerve stimulation against depression-like behaviors via hypothalamic α7nAchR / JAK2 / STAT3 / NF-κB pathway in rats exposed to chronic unpredictable mild stress. CNS Neurosci. Ther. 2023 29 9 2634 2644 10.1111/cns.14207 37032645
    [Google Scholar]
  70. Winiarska-Mieczan A. Kwiecień M. Jachimowicz-Rogowska K. Donaldson J. Tomaszewska E. Baranowska-Wójcik E. Anti-inflammatory, antioxidant, and neuroprotective effects of polyphenols—polyphenols as an element of diet therapy in depressive disorders. Int. J. Mol. Sci. 2023 24 3 2258 10.3390/ijms24032258 36768580
    [Google Scholar]
  71. Cheng Y. Desse S. Martinez A. Worthen R.J. Jope R.S. Beurel E. TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav. Immun. 2018 69 556 567 10.1016/j.bbi.2018.02.003 29452218
    [Google Scholar]
  72. Zheng P. Zeng B. Zhou C. Liu M. Fang Z. Xu X. Zeng L. Chen J. Fan S. Du X. Zhang X. Yang D. Yang Y. Meng H. Li W. Melgiri N.D. Licinio J. Wei H. Xie P. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol. Psychiatry 2016 21 6 786 796 10.1038/mp.2016.44 27067014
    [Google Scholar]
  73. O’Connor J.C. Lawson M.A. André C. Moreau M. Lestage J. Castanon N. Kelley K.W. Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009 14 5 511 522 10.1038/sj.mp.4002148 18195714
    [Google Scholar]
  74. O’Connor J.C. Lawson M.A. André C. Briley E.M. Szegedi S.S. Lestage J. Castanon N. Herkenham M. Dantzer R. Kelley K.W. Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J. Immunol. 2009 182 5 3202 3212 10.4049/jimmunol.0802722 19234218
    [Google Scholar]
  75. Iwata M. Ota K.T. Li X.Y. Sakaue F. Li N. Dutheil S. Banasr M. Duric V. Yamanashi T. Kaneko K. Rasmussen K. Glasebrook A. Koester A. Song D. Jones K.A. Zorn S. Smagin G. Duman R.S. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol. Psychiatry 2016 80 1 12 22 10.1016/j.biopsych.2015.11.026 26831917
    [Google Scholar]
  76. Niklasson F. Agren H. Brain energy metabolism and blood-brain barrier permeability in depressive patients: Analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biol. Psychiatry 1984 19 8 1183 1206 6498242
    [Google Scholar]
  77. Rogers G.B. Keating D.J. Young R.L. Wong M-L. Licinio J. Wesselingh S. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol. Psychiatry 2016 21 6 738 748 10.1038/mp.2016.50 27090305
    [Google Scholar]
  78. Lin P. Li D. Shi Y. Li Q. Guo X. Dong K. Chen Q. Lou X. Li Z. Li P. Jin W. Chen S. Sun Y. Sun J. Cheng X. Dysbiosis of the gut microbiota and kynurenine (Kyn) pathway activity as potential biomarkers in patients with major depressive disorder. Nutrients 2023 15 7 1752 10.3390/nu15071752 37049591
    [Google Scholar]
  79. Alcocer-Gómez E. de Miguel M. Casas-Barquero N. Núñez-Vasco J. Sánchez-Alcazar J.A. Fernández-Rodríguez A. Cordero M.D. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav. Immun. 2014 36 111 117 10.1016/j.bbi.2013.10.017 24513871
    [Google Scholar]
  80. Murphy M.M. Can menopause cause autonomic dysreflexia? SCI Nurs. 1991 8 3 83 1891705
    [Google Scholar]
  81. Black D.S. O’Reilly G.A. Olmstead R. Breen E.C. Irwin M.R. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: A randomized clinical trial. JAMA Intern. Med. 2015 175 4 494 501 10.1001/jamainternmed.2014.8081 25686304
    [Google Scholar]
  82. Rethorst C.D. Toups M.S. Greer T.L. Nakonezny P.A. Carmody T.J. Grannemann B.D. Huebinger R.M. Barber R.C. Trivedi M.H. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol. Psychiatry 2013 18 10 1119 1124 10.1038/mp.2012.125 22925832
    [Google Scholar]
  83. Sampson E. Kavakbasi E. Mills N.T. Hori H. Schubert K.O. Fourrier C. Baune B.T. Emotional blunting in depression in the PREDDICT clinical trial: Inflammation-stratified augmentation of vortioxetine with celecoxib. Int. J. Neuropsychopharmacol. 2024 27 3 pyad066 10.1093/ijnp/pyad066 38441216
    [Google Scholar]
  84. Herbert T.B. Cohen S. Depression and immunity: A meta-analytic review. Psychol. Bull. 1993 113 3 472 486 10.1037/0033‑2909.113.3.472 8316610
    [Google Scholar]
  85. Wetsman N. Inflammatory illness: Why the next wave of antidepressants may target the immune system. Nat. Med. 2017 23 9 1009 1011 10.1038/nm0917‑1009 28886000
    [Google Scholar]
  86. Thombs B.D. Bass E.B. Ford D.E. Stewart K.J. Tsilidis K.K. Patel U. Fauerbach J.A. Bush D.E. Ziegelstein R.C. Prevalence of depression in survivors of acute myocardial infarction. J. Gen. Intern. Med. 2006 21 1 30 38 10.1111/j.1525‑1497.2005.00269.x 16423120
    [Google Scholar]
  87. Whooley M.A. Depression and cardiovascular disease: Healing the broken-hearted. JAMA 2006 295 24 2874 2881 10.1001/jama.295.24.2874 16804154
    [Google Scholar]
  88. Lane M.M. Gamage E. Du S. Ashtree D.N. McGuinness A.J. Gauci S. Baker P. Lawrence M. Rebholz C.M. Srour B. Touvier M. Jacka F.N. O’Neil A. Segasby T. Marx W. Ultra-processed food exposure and adverse health outcomes: Umbrella review of epidemiological meta-analyses. BMJ 2024 384 e077310 10.1136/bmj‑2023‑077310 38418082
    [Google Scholar]
  89. Mehdi S.M.A. Costa A.P. Svob C. Pan L. Dartora W.J. Talati A. Gameroff M.J. Wickramaratne P.J. Weissman M.M. McIntire L.B.J. Depression and cognition are associated with lipid dysregulation in both a multigenerational study of depression and the national health and nutrition examination survey. Transl. Psychiatry 2024 14 1 142 10.1038/s41398‑024‑02847‑6 38467624
    [Google Scholar]
  90. Shen R. Zou T. The association between cardiovascular health and depression: Results from the 2007–2020 NHANES. Psychiatry Res. 2024 331 115663 10.1016/j.psychres.2023.115663 38064908
    [Google Scholar]
  91. Shiga T. Depression and cardiovascular diseases. J. Cardiol. 2023 81 5 485 490 10.1016/j.jjcc.2022.11.010 36410589
    [Google Scholar]
  92. Kim H. Lee Y.B. Lee J. Kang D. Kim G. Jin S.M. Kim J.H. Hur K.Y. Jeon H.J. Association between depression, antidepressant use, and the incidence of atherosclerotic cardiovascular diseases. J. Affect. Disord. 2024 352 214 221 10.1016/j.jad.2024.02.034 38378089
    [Google Scholar]
  93. Krittanawong C. Maitra N.S. Qadeer Y.K. Wang Z. Fogg S. Storch E.A. Celano C.M. Huffman J.C. Jha M. Charney D.S. Lavie C.J. Association of depression and cardiovascular disease. Am. J. Med. 2023 136 9 881 895 10.1016/j.amjmed.2023.04.036 37247751
    [Google Scholar]
  94. Willner P. Animal models of depression: Validity and applications. Adv. Biochem. Psychopharmacol. 1995 49 19 41 7653333
    [Google Scholar]
  95. Hollis F. Kabbaj M. Social defeat as an animal model for depression. ILAR J. 2014 55 2 221 232 10.1093/ilar/ilu002 25225302
    [Google Scholar]
  96. Planchez B Surget A Belzung C Animal models of major depression: Drawbacks and challenges. J Neural Transm (Vienna). 2019 126 11 1383 1408 10.1007/s00702‑019‑02084‑y
    [Google Scholar]
  97. Tse W.S. Pochwat B. Szewczyk B. Misztak P. Bobula B. Tokarski K. Worch R. Czarnota-Bojarska M. Lipton S.A. Zaręba-Kozioł M. Bijata M. Wlodarczyk J. Restorative effect of NitroSynapsin on synaptic plasticity in an animal model of depression. Neuropharmacology 2023 241 109729 10.1016/j.neuropharm.2023.109729 37797736
    [Google Scholar]
  98. Mingardi J. Ndoj E. Bonifacino T. Misztak P. Bertoli M. La Via L. Torazza C. Russo I. Milanese M. Bonanno G. Popoli M. Barbon A. Musazzi L. Functional and molecular changes in the prefrontal cortex of the chronic mild stress rat model of depression and modulation by acute ketamine. Int. J. Mol. Sci. 2023 24 13 10814 10.3390/ijms241310814 37445990
    [Google Scholar]
  99. Gonzales E.L. Jeon S.J. Han K.M. Yang S.J. Kim Y. Remonde C.G. Ahn T.J. Ham B.J. Shin C.Y. Correlation between immune-related genes and depression-like features in an animal model and in humans. Brain Behav. Immun. 2023 113 29 43 10.1016/j.bbi.2023.06.017 37379963
    [Google Scholar]
  100. Fu Q. Qiu R. Chen L. Chen Y. Qi W. Cheng Y. Music prevents stress-induced depression and anxiety-like behavior in mice. Transl. Psychiatry 2023 13 1 317 10.1038/s41398‑023‑02606‑z 37828015
    [Google Scholar]
  101. Afridi R. Suk K. Neuroinflammatory basis of depression: Learning from experimental models. Front. Cell. Neurosci. 2021 15 691067 10.3389/fncel.2021.691067 34276311
    [Google Scholar]
  102. Matthews K. Christmas D. Swan J. Sorrell E. Animal models of depression: Navigating through the clinical fog. Neurosci. Biobehav. Rev. 2005 29 4-5 503 513 10.1016/j.neubiorev.2005.03.005 15925695
    [Google Scholar]
  103. McArthur R. Borsini F. Animal models of depression in drug discovery: A historical perspective. Pharmacol. Biochem. Behav. 2006 84 3 436 452 10.1016/j.pbb.2006.06.005 16844210
    [Google Scholar]
  104. Wang Y.L. Han Q.Q. Gong W.Q. Pan D.H. Wang L.Z. Hu W. Yang M. Li B. Yu J. Liu Q. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. J. Neuroinflammation 2018 15 1 21 10.1186/s12974‑018‑1054‑3 29343269
    [Google Scholar]
  105. Guilarte T.R. TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward. Pharmacol. Ther. 2019 194 44 58 10.1016/j.pharmthera.2018.09.003 30189290
    [Google Scholar]
  106. De Picker L.J. Morrens M. Branchi I. Haarman B.C.M. Terada T. Kang M.S. Boche D. Tremblay M.E. Leroy C. Bottlaender M. Ottoy J. TSPO PET brain inflammation imaging: A transdiagnostic systematic review and meta-analysis of 156 case-control studies. Brain Behav. Immun. 2023 113 415 431 10.1016/j.bbi.2023.07.023 37543251
    [Google Scholar]
  107. Holmes SE Abdallah C Esterlis I Imaging synaptic density in depression. Neuropsychopharmacology 2023 48 1 186 190 10.1038/s41386‑022‑01368‑4
    [Google Scholar]
  108. Zhou E. Wang W. Ma S. Xie X. Kang L. Xu S. Deng Z. Gong Q. Nie Z. Yao L. Bu L. Wang F. Liu Z. Prediction of anxious depression using multimodal neuroimaging and machine learning. Neuroimage 2024 285 120499 10.1016/j.neuroimage.2023.120499 38097055
    [Google Scholar]
  109. De Palma G. Blennerhassett P. Lu J. Deng Y. Park A.J. Green W. Denou E. Silva M.A. Santacruz A. Sanz Y. Surette M.G. Verdu E.F. Collins S.M. Bercik P. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun. 2015 6 1 7735 10.1038/ncomms8735 26218677
    [Google Scholar]
  110. Jeong S. Chokkalla A.K. Davis C.K. Vemuganti R. Post-stroke depression: Epigenetic and epitranscriptomic modifications and their interplay with gut microbiota. Mol. Psychiatry 2023 28 10 4044 4055 10.1038/s41380‑023‑02099‑8 37188778
    [Google Scholar]
  111. Varesi A. Campagnoli L.I.M. Chirumbolo S. Candiano B. Carrara A. Ricevuti G. Esposito C. Pascale A. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches. Pharmacol. Res. 2023 192 106799 10.1016/j.phrs.2023.106799 37211239
    [Google Scholar]
  112. Zhou M. Fan Y. Xu L. Yu Z. Wang S. Xu H. Zhang J. Zhang L. Liu W. Wu L. Yu J. Yao H. Wang J. Gao R. Microbiome and tryptophan metabolomics analysis in adolescent depression: Roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome 2023 11 1 145 10.1186/s40168‑023‑01589‑9 37386523
    [Google Scholar]
  113. Lyra e Silva N.M. Barros-Aragão F.G.Q. De Felice F.G. Ferreira S.T. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology 2022 209 109023 10.1016/j.neuropharm.2022.109023 35257690
    [Google Scholar]
  114. Mazza M.G. Palladini M. De Lorenzo R. Magnaghi C. Poletti S. Furlan R. Ciceri F. Rovere-Querini P. Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021 94 138 147 10.1016/j.bbi.2021.02.021 33639239
    [Google Scholar]
  115. Taquet M. Geddes J.R. Husain M. Luciano S. Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry 2021 8 5 416 427 10.1016/S2215‑0366(21)00084‑5 33836148
    [Google Scholar]
  116. Tan Y. Xie Y. Dong G. Yin M. Shang Z. Zhou K. Bao D. Zhou J. The effect of 14-day consumption of hydrogen-rich water alleviates fatigue but does not ameliorate dyspnea in long-COVID patients: A pilot, single-blind, and randomized, controlled trial. Nutrients 2024 16 10 1529 10.3390/nu16101529 38794767
    [Google Scholar]
  117. Farahani R.H. Ajam A. Naeini A.R. Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial. BMC Infect. Dis. 2023 23 1 197 10.1186/s12879‑023‑08172‑5 37003990
    [Google Scholar]
  118. Zhang J. Song L. Jia J. Tian W. Lai R. Zhang Z. Li J. Ju J. Xu H. Knowledge mapping of necroptosis From 2012 to 2021: A bibliometric analysis. Front. Immunol. 2022 13 917155 10.3389/fimmu.2022.917155 35769473
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303325541241024060229
Loading
Beyond the Surface: Tracing the Evolution of Inflammatory Mechanism in Depression through Bibliometric Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0118715303325541241024060229
/content/journals/emiddt/10.2174/0118715303325541241024060229
/content/journals/emiddt/10.2174/0118715303325541241024060229
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: citeSpace ; WoSCC ; neuroimmunology ; bibliometric ; Depression ; inflammation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test